(5R)-1,5-dimethylpiperazin-2-one(CAS: 1068149-96-1)

The regulatory guidelines for (5R)-1,5-dimethylpiperazin-2-one (CAS: 1068149-96-1) include GHS classification, which categorizes it based on its physical and health hazards. For European markets, REACH regulations apply, requiring registration based on the substance's properties and uses. FDA and EPA regulations may also be relevant, particularly in the context of pharmaceuticals and environmental safety.

Several alternatives to (5R)-1,5-dimethylpiperazin-2-one (CAS: 1068149-96-1) can be used in synthesis, such as other cyclic amides like 1,5-dimethylpiperazine or related compounds like 1,4-dimethylpiperazin-2-one. These alternatives offer similar structural features and can be chosen based on specific reaction requirements and availability.

The market for (5R)-1,5-dimethylpiperazin-2-one (CAS: 1068149-96-1) is growing due to its use in pharmaceuticals and drug development. Research trends focus on its applications in central nervous system drug discovery, particularly for pain management and neurodegenerative diseases. Increasing interest in novel therapeutic approaches drives demand for this compound.

Waste containing (5R)-1,5-dimethylpiperazin-2-one (CAS: 1068149-96-1) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration or chemical treatment may be necessary to ensure complete decomposition. Environmental protection measures include proper labeling and handling to prevent contamination of soil and water sources.